Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:KRMDNASDAQ:LNSRNASDAQ:RCELOTCMKTS:UEEC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKRMDKORU Medical Systems$3.23$2.74$1.86▼$5.05$149.04M0.43135,647 shs174,859 shsLNSRLENSAR$12.22-2.2%$13.67$3.50▼$17.31$144.10M0.5282,926 shs151,285 shsRCELAVITA Medical$5.47-1.3%$7.69$5.31▼$14.16$144.60M1.55184,052 shs152,970 shsUEECUnited Health Products$0.13-1.9%$0.22$0.05▼$0.28$32.66M-1.36129,342 shs56,296 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKRMDKORU Medical Systems0.00%+4.87%+9.49%+8.75%+50.93%LNSRLENSAR0.00%-4.65%-11.41%-19.77%+169.98%RCELAVITA Medical0.00%-9.33%-14.24%-38.65%-33.81%UEECUnited Health Products0.00%-21.10%-46.02%-25.00%-21.63%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKRMDKORU Medical Systems3.3273 of 5 stars3.55.00.00.02.12.50.6LNSRLENSAR1.4015 of 5 stars2.03.00.00.02.82.50.0RCELAVITA Medical1.5063 of 5 stars3.40.00.00.03.40.00.6UEECUnited Health Products0.7465 of 5 stars0.05.00.00.02.80.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKRMDKORU Medical Systems 3.00Buy$4.5039.32% UpsideLNSRLENSAR 2.00Hold$15.0022.75% UpsideRCELAVITA Medical 2.75Moderate Buy$16.50201.65% UpsideUEECUnited Health Products 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest UEEC, RCEL, LNSR, and KRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025RCELAVITA MedicalD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$19.005/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.504/10/2025RCELAVITA MedicalD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$22.00 ➝ $22.004/4/2025RCELAVITA MedicalD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$22.00 ➝ $22.003/24/2025LNSRLENSARBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/24/2025LNSRLENSARLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$16.00 ➝ $15.003/18/2025RCELAVITA MedicalD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$22.00 ➝ $22.00(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKRMDKORU Medical Systems$35.08M4.25N/AN/A$0.45 per share7.18LNSRLENSAR$57.07M2.53N/AN/A$2.97 per share4.11RCELAVITA Medical$71.66M2.02N/AN/A$0.17 per share32.18UEECUnited Health Products$40K816.50N/AN/A($0.01) per share-12.75Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKRMDKORU Medical Systems-$13.74M-$0.11N/AN/AN/A-37.42%-24.60%-16.87%8/6/2025 (Estimated)LNSRLENSAR-$14.38M-$4.85N/A∞N/A-34.03%-49.02%-21.12%8/6/2025 (Estimated)RCELAVITA Medical-$61.85M-$2.19N/AN/AN/A-96.26%-337.91%-71.50%8/6/2025 (Estimated)UEECUnited Health Products-$2.62M-$0.02N/A∞N/AN/AN/A-840.17%N/ALatest UEEC, RCEL, LNSR, and KRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025LNSRLENSAR-$0.1550-$2.32-$2.1650-$2.32$13.40 million$11.53 million5/8/2025Q1 2025RCELAVITA Medical-$0.39-$0.53-$0.14-$0.53$33.15 million$18.51 million5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 million3/28/2025Q4 2024UEECUnited Health ProductsN/A-$0.01N/A-$0.01N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKRMDKORU Medical SystemsN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/ARCELAVITA MedicalN/AN/AN/AN/AN/AUEECUnited Health ProductsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKRMDKORU Medical Systems0.012.992.37LNSRLENSARN/A3.372.10RCELAVITA Medical9.392.832.47UEECUnited Health ProductsN/A0.030.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKRMDKORU Medical Systems58.60%LNSRLENSAR40.15%RCELAVITA Medical27.66%UEECUnited Health Products0.07%Insider OwnershipCompanyInsider OwnershipKRMDKORU Medical Systems20.60%LNSRLENSAR38.52%RCELAVITA Medical2.80%UEECUnited Health Products1.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableKRMDKORU Medical Systems8046.14 million34.10 millionOptionableLNSRLENSAR11011.79 million7.14 millionOptionableRCELAVITA Medical13026.44 million25.74 millionOptionableUEECUnited Health Products4256.16 million246.33 millionNot OptionableUEEC, RCEL, LNSR, and KRMD HeadlinesRecent News About These CompaniesShort Interest in United Health Products, Inc. (OTCMKTS:UEEC) Declines By 75.0%June 14 at 2:53 AM | americanbankingnews.comUnited Health Products (OTCMKTS:UEEC) Shares Down 6.4% - Here's What HappenedJune 11, 2025 | americanbankingnews.comUnited Health Products Provides Regulatory Application UpdateJune 6, 2025 | finance.yahoo.comUnited Health Products, Inc. (OTCMKTS:UEEC) Short Interest Down 89.6% in MayMay 30, 2025 | marketbeat.comUnited Health Products (OTCMKTS:UEEC) Shares Down 4.7% - Here's What HappenedMay 22, 2025 | marketbeat.comUnited Health Products Announces OTCQB Uplisting and FDA UpdateMay 1, 2025 | finance.yahoo.comUnited Health Products Provides Update on FDA and OTC Markets ApplicationsMarch 28, 2025 | finance.yahoo.comUnited Health Products Provides Update on Capital Markets and Regulatory ProcessesMarch 14, 2025 | finance.yahoo.comUnited Health Products Provides Update on Clinical Study ProcessDecember 2, 2024 | globenewswire.com2 recalls impacting Lubbock area supermarkets, including H-E-B, Walmart, UnitedOctober 31, 2024 | yahoo.comUnited Laboratories’ Antibiotic Product Gains Key ApprovalOctober 26, 2024 | msn.comEco Bandage, Greener Living Products receive ECRM Health Care Buyers’ Choice AwardsOctober 14, 2024 | drugstorenews.comUnited overhauls economy-class wine menu with 4 new optionsOctober 1, 2024 | thepointsguy.comUnited Supermarkets Partners on New Health Care BenefitSeptember 30, 2024 | progressivegrocer.comRising Extreme Heat Compounds the U.S. Maternal Health CrisisSeptember 30, 2024 | americanprogress.orgUnited Healthcare cuts UF Health from in-provider networkSeptember 5, 2024 | mainstreetdailynews.comUnited Therapeutics: Strong Buy Rating on FDA Exclusivity and Market Dominance for Tyvaso DPIAugust 20, 2024 | markets.businessinsider.comUnited Health Products Submits Response Letter to FDAAugust 19, 2024 | globenewswire.comFDA warns producer about lead levels in its apple cinnamon puree productsAugust 17, 2024 | msn.comUnitedHealthcare: Health care coverage and benefitsAugust 14, 2024 | unitedhealthgroup.comHealth Headlines: How to spot ultra-processed foodsAugust 13, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUEEC, RCEL, LNSR, and KRMD Company DescriptionsKORU Medical Systems NASDAQ:KRMD$3.23 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$3.24 +0.01 (+0.31%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.LENSAR NASDAQ:LNSR$12.22 -0.28 (-2.24%) Closing price 04:00 PM EasternExtended Trading$12.24 +0.02 (+0.17%) As of 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.AVITA Medical NASDAQ:RCEL$5.47 -0.07 (-1.26%) Closing price 04:00 PM EasternExtended Trading$5.46 -0.01 (-0.18%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.United Health Products OTCMKTS:UEEC$0.13 0.00 (-1.92%) As of 06/13/2025 12:28 PM EasternUnited Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore SoundHound’s AI Growth Story Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
